Clinical trial
A Questionnaire Based Study on Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia (HHT)
NCT02690246 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Questionnaire Based Study on Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia (HHT)
- Lead sponsor
- University Hospital, Essen
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- March 31, 2021
- Enrollment
- 915 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary haemorrhagic telangiectasia (hht)